Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Drug Discovery, Development and Other Pharmaceutical Applications

Abstract:
2 1/2 day short course the University of Wisconsin

Nanotechnology: Drug Discovery, Development and Other Pharmaceutical Applications



University of Wisconsin, Madison

Madison, WI | February 21, 2005

Industrial Short Course
May 16-18, 2005
Madison, WI


Nanotechnology along with biotechnology and bioinformatics constitute the basis of 21st Century therapeutics with joint ventures and collaborations between academia, government and industry. Advances in Nanotechnology have indeed revolutionized our thinking from research, engineering and business perspectives. It is the purpose of this course to provide the participants with the state-of-art in nanoscience and nanotechnology as applied to drug discovery, delivery and development.

Nanotechnology for biotech and pharmaceutical applications has progressed from the concept stage to commercialization. Improving the develop-ability of new molecules and the efficacy and delivery of existing drugs is the key to a successful future. In this course, an overview and key highlights of nanotechnology and its diverse applications will be featured first along with an overview of nanoscience and nanotechnology programs and initiatives at the NIH.

The primary objective in this course is to upgrade the knowledge of pharmaceutical personnel, who can then be of greater value to their respective firms. Students will work closely with the faculty members to allow for optimum dialogue and discussion. To allow for maximum faculty-student interaction, the enrollment will be limited to 30 registrants. As with all UW School of Pharmacy programs, it is designed to be practical and applicable to participants' work environments.

The general session of the course will include a series of topics in nanobiotechnology, such as nanobiosensors and nanogenomics and their impact to drug discovery. Polymer- and lipid-based micro-and nanostructures will be discussed next and illustrated with case studies where these systems have been successfully used throughout the drug development value chain.

Upon completion of the course, the learner should be able to:

  • discuss the state-of-art in the pharmaceutical applications of nanotechnology
  • understand the potential benefits of drug formulation using lipid- and polymer-based nanocarriers and their integration into their i ntellectual property and product portfolios
  • identify opportunities in microfabrication of materials and tissue engineering
  • better predict the develop-ability of new chemical entities and anticipate commercialization challenges and opportunities
  • apply rational, timely and target-driven design of nanopharmaceuticals

For more information, visit the course webpage.

####


Courses are presented on the University of Wisconsin-Madison campus. Springtime in Madison and the beauty of the on-campus location provide a relaxing atmosphere for learning. Evenings are free to explore the University and the city.



Copyright © University of Wisconsin

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Academic/Education

Luleå University of Technology is using the Deben CT5000TEC stage to perform x-ray microtomography experiments with the ZEISS Xradia 510 Versa to understand deformation and strain inside inhomogeneous materials November 7th, 2017

Park Systems Announces the Grand Opening of the Park NanoScience Center at SUNY Polytechnic Institute November 3rd, 2017

Two Scientists Receive Grants to Develop New Materials: Chad Mirkin and Monica Olvera de la Cruz recognized by Sherman Fairchild Foundation August 16th, 2017

Moving at the Speed of Light: University of Arizona selected for high-impact, industrial demonstration of new integrated photonic cryogenic datalink for focal plane arrays: Program is major milestone for AIM Photonics August 10th, 2017

Nanomedicine

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy — Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 — December 6th, 2017

Copper will replace toxic palladium and expensive platinum in the synthesis of medications: The effectiveness of copper nanoparticles as a catalyst has been proven December 5th, 2017

Researchers advance technique to detect ovarian cancer: Rice, MD Anderson use fluorescent carbon nanotube probes to achieve first in vivo success November 30th, 2017

Announcements

UCLA chemists synthesize narrow ribbons of graphene using only light and heat: Tiny structures could be next-generation solution for smaller electronic devices December 8th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Device makes power conversion more efficient: New design could dramatically cut energy waste in electric vehicles, data centers, and the power grid December 8th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project